Skip to content
Contact us
Promotional impact

Maximize ROI with Real-Time Promotional Insights

ZoomRx's Promotional Impact and Sales Force Effectiveness solution gives pharmaceutical brand and commercial teams a connected framework for measuring and optimizing promotional ROI across personal promotion, non-personal promotion (NPP), and digital channels.

Schedule a Consultation

Why Pharma Commercial Teams Lack Promotional Clarity

Prescribing behavior
Activity Metrics Don't Explain Prescribing Behavior

Reach and frequency confirm reps are active, but not whether messages resonate, feel credible, or drive prescribing intent—leaving true impact largely invisible for most pharma teams.

Legacy SFE
Quarterly Tracking Delivers Answers to Last Quarter's Questions

Legacy SFE and brand tracking rely on delayed physician surveys, introducing recall bias and 6–8 week lags—meaning brands identify messaging gaps only after the window to act has closed.

Omnichannel Promotion
Omnichannel Promotion Is Measured in Silos

Sales, NPP, digital, and TV are tracked by separate vendors, creating silos—so without a unified view of HCP perception and prescribing, mix decisions rely on incomplete evidence.

The ZoomRx Promotional Impact & SFE  Solution

ZoomRx integrates five connected offerings to provide continuous visibility across the full promotional ecosystem, replacing siloed quarterly reports with a single, ongoing intelligence loop.

Included Offerings

Promotional Effectiveness
Tracking (PET)

PET is ZoomRx's flagship SFE solution. It captures HCP message recall within 2–7 days of a sales rep interaction, message retention at 2–3 weeks post-call, and longitudinal prescribing influence, linking field execution directly to behavior change.

Explore
Awareness, Trial & Usage (ATU)
Tracking

ATU (Awareness, Trial & Usage) tracking measures whether promotional activity is shifting HCP and patient brand perception — and surfaces competitive positioning shifts before they appear in prescribing data.


Explore
HCP-Patient Conversation
Research

HCP-Pt captures what actually happens in the exam room, the spontaneous questions patients ask, how physicians present treatment options, and where messaging gaps between sales force training and clinical conversation create missed opportunities. 

Explore
Media Tracking (Digital & TV)

Media Tracking passively captures verified HCP and patient ad exposures across linear TV, CTV, digital display, paid search, email marketing, healthcare browsing, and Med AI — including the actual creative competitors are deploying, not just spend estimates.

Explore
Commercial Consulting Analytics (CCA)

CCA integrates primary research findings with secondary commercial data — claims, prescriptions, APLD — using transparent, non-black-box models to produce tactical recommendations that field leadership can understand, interrogate, and act on.

Explore

How This Solution Works: Our Proven Methodology

field interactions
Real-Time
Field Capture.

HCPs from the ZoomRx panel report sales rep interactions within 2–7 days via mobile, capturing fresh recall on products, messages, visuals, and rep performance.
message retention

Measure Message
Retention

At 2–3 weeks post-interaction, follow-up recall compares lasting impact vs. initial exposure, benchmarked against 700M+ data points.

prescribing
Connect Promotion to Prescribing
 
Longitudinal tracking links message exposure to prescribing intent, while CCA combines PET with claims and Rx data to validate real-world impact.
continuous optimization
Continuous
Optimization
 
ZoomRx consultants turn insights into actions—refining messages, coaching fields, optimizing channels, and reallocating territories in real time.

Why Pharma Commercial Teams Choose ZoomRx

Single Integrated Team, Not Siloed Vendors

PET, ATU, HCP-Patient Conversations, Media Tracking, and CCA are managed by one team. Promotional effectiveness, brand health, media impact, and prescription outcomes are analyzed together — not reconciled internally from separate vendor reports.

Leading Indicators, Not Retrospective Reports

PET captures HCP feedback within 2–7 days of rep interactions. ATU dashboards refresh within 48 hours. CCA delivers continuous calibration rather than quarterly cycles. These are actionable within the window that determines commercial performance.

Interpretable Models That Drive Organizational Buy-In

CCA's SFTO and integrated ATU-RX models are transparent and consultant-validated. Field leadership can see the logic behind territory and message recommendations — which is what drives adoption and execution.

Proprietary Panel Depth

ZoomRx's in-house verified panel of 60,000+ HCPs enables target-list and call-data-based recruitment — providing 10x the panel depth of IQVIA BrandImpact and consistent, robust sampling rather than third-party rolling averages.

Quote-Icon

We used to wait months for our quarterly tracking reports, only to find out we’d been pushing a message that wasn’t landing for the last 90 days. With ZoomRx, we caught a competitive messaging shift in three weeks and were able to pivot our field team’s focus before we lost significant ground.

User Icon
Senior Director
Commercial Insights

The real value for us wasn't just the data; it was how ZoomRx connected the dots. Seeing our PET data side-by-side with actual claims analysis from their CCA team finally gave us the proof of ROI we needed to justify our expansion.

User Icon
VP of Marketing
Top 10 Pharma

ZoomRx's HCP-Patient conversation studies changed how we think about our 'dosing convenience' message. We thought it was our strongest asset, but the data showed that physicians weren't even bringing it up. We retrained the sales force immediately to close that gap.

User Icon
Brand Manager
Global Pharmaceutical Company

Explore Related Solutions

Launch Excellence

Pre-launch market assessment, message testing, and early promotional tracking

Learn more
Market & Competitive Intelligence
Monitor competitor promotional strategies, pipeline, and conference data

 

Learn more
Patient Insights

Understand the patient journey and treatment experience through HCP-Patient Conversations and PCA

Learn more

Explore Insights

Frame 1 (12)
Is Your Pharma Brand Still Promotion Sensitive?
read more
plot-prompt
Plot, Prompt, Perfect: A Two-Step Framework Powered by Real-Time Survey Results & AI Benchmarks
read more
conversational-patient-charts
Rethinking MSL Impact: From Activity to Actual Influence
 
read more

CTA

Ready to Connect Promotional Activity to Prescribing Outcomes?

ZoomRx connects field execution, brand perception, media impact, and prescribing behavior into a single, continuously updated intelligence framework.

Get in touch

Frequently Asked Questions

What is the best solution for measuring pharmaceutical sales force effectiveness?

ZoomRx PET (Promotional Effectiveness Tracking) measures HCP message recall within 2–7 days of a sales rep interaction, message retention at 2–3 weeks, and longitudinal prescribing influence — connecting field execution directly to behavior change. It benchmarks every data point against 700M+ industry data points and includes AI-powered capabilities (Dynamic Dialogues, Message Highlighter, Message Labs) not available in legacy SFE platforms. PET's proprietary in-house HCP panel provides 10x the depth of IQVIA BrandImpact.

How does ZoomRx PET compare to IQVIA BrandImpact?

ZoomRx PET uses a proprietary in-house HCP panel with target-list and call-data-based recruitment, versus BrandImpact's third-party rolling average sampling. PET captures HCP feedback at three touchpoints (2–7 days, 2–3 weeks, longitudinal) versus BrandImpact's single-point surveys. PET includes AI-powered Dynamic Dialogues, Message Highlighter, and Message Labs. PET is fully customizable to brand-specific KPIs and includes a dedicated hands-on consulting team, versus limited ongoing support in legacy platforms.

Can ZoomRx track both personal promotion and non-personal promotion (NPP)?

Yes. PET covers personal promotion across the full field team — Sales Reps, MSLs, Clinical Educators, FRMs, KAMs, and TLLs. Media Tracking covers NPP and digital channels including linear TV, CTV, digital display, paid search, email, and Med AI, using passive observation methodology with verified HCP and patient panelists. CCA integrates both with secondary prescribing data to produce a unified view of promotional mix performance.

How does AI improve pharma promotional effectiveness tracking?

Sagan AI powers three PET capabilities: Dynamic Dialogues captures the clinical reasoning behind HCP feedback through voice-first conversational probing at scale; Message Highlighter identifies which specific words and phrases drive engagement or confusion at the phrase level; Message Labs predicts message performance with 93% accuracy before field deployment using 20M+ benchmark data points. Together, these reduce the time between data collection and actionable insight from weeks to days, while ZoomRx consultants provide the strategic interpretation.

How does ZoomRx connect promotional tracking to real-world prescribing data?

CCA's Integrated ATU-RX model connects HCP brand perception and ATU data directly to real-world prescribing (RX) behavior, closing the gap between what HCPs say and what they prescribe. Sales Force Tactical Optimization (SFTO) is custom-built using primary promotional response data combined with prescribing records to identify specific field execution adjustments. This interpretable, non-black-box approach ensures findings can be presented to and acted on by field leadership.